Pharvaris N.V.

NASDAQ:PHVS

Biotechnology

Healthcare
$31.66 -1.93%

-$0.64 today

Market cap
$2.22B
Beta
-2.33
P/E (TTM)
-11.0
EPS (TTM)
-$2.59
52W Low $16.72High $34.41

Volume 0.28M

Average 0.31M

Price history

Pharvaris N.V. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+30.83%

Period high

$38.86

Period low

$23.68

Latest

$31.66

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
SC 13G/ANov 13, 2026Nov 13, 2026
4Nov 12, 2026Nov 12, 2026
6-KNov 12, 2026Nov 12, 2026
4Oct 13, 2026Oct 13, 2026
4Sep 25, 2026Sep 25, 2026
4Sep 24, 2026Sep 24, 2026
4Sep 24, 2026Sep 24, 2026
4Sep 23, 2026Sep 23, 2026
4Sep 21, 2026Sep 21, 2026
4Sep 21, 2026Sep 21, 2026
4Sep 21, 2026Sep 21, 2026
4Sep 21, 2026Sep 21, 2026
4Sep 21, 2026Sep 21, 2026
4Sep 21, 2026Sep 21, 2026
4Sep 17, 2026Sep 17, 2026

Competitors

Who does Pharvaris N.V. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about PHVS's filings, answered from its disclosures.

What is the latest PHVS filing?

The latest filing shown is SC 13G/A dated Nov 13, 2026.

How many recent filings does PHVS have?

Intrinsic Alpha currently shows 20 recent filings for PHVS.